Hamps Bio — 360° view

Hamps Bio, a company in the Other Agricultural Products industry, reported revenue of ₹7.31 crore and net profit of ₹0.20 crore for the September 2026 quarter.

Hamps Bio (BSE: HAMPS) closed at ₹25.50 on 20 Nov 2026, up 4.1% over the past year. Its market capitalisation is ₹22 crore.

Share price
₹25.50 (20 Nov 2026)
Market cap
₹22 Cr (20 Nov 2026)
Revenue
₹7 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
-3.36% (FY26)
ROE
-8.76% (FY26)
Book value
₹9.54 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹26.58 / ₹13.36 (20 Nov 2026)
1-year return
4.1% (to 20 Nov 2026)
Sector
Fast Moving Consumer Goods
Industry
Other Agricultural Products
Symbol
BSE: HAMPS

Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.